
Thermo Fisher Scientific (TMO) and Eli Lilly (LLY) both experienced notable options trading volume, with TMO's options activity representing 41.5% of its average daily share volume and LLY's at 40.4%. Specifically, TMO saw high volume in its November 2025 $550 strike call options, while LLY had significant interest in its October 2025 $950 strike call options. This elevated activity in long-dated call options suggests increased speculative interest or hedging strategies targeting these specific price levels for both pharmaceutical giants.
Thermo Fisher Scientific (TMO) and Eli Lilly (LLY) recently exhibited significant options trading volume, representing 41.5% and 40.4% of their respective average daily share volumes over the past month. Notably, TMO saw elevated activity in its November 2025 $550 strike call options with 3,868 contracts, while LLY experienced high volume in its October 2025 $950 strike call options, trading 1,148 contracts. This concentrated interest in long-dated, out-of-the-money call options suggests either increased speculative bullish positioning or sophisticated hedging strategies targeting substantial upside for both pharmaceutical and life sciences giants. Such activity indicates a notable conviction among a segment of options traders regarding future price appreciation or a need to protect against significant upward moves. Despite this specific options market activity, the overall sentiment for both TMO and LLY, as well as the broader market impact, remains neutral according to provided signals. This suggests that while options traders are positioning, the underlying share prices or general market perception have not yet reacted strongly to this flow. However, elevated options volume, particularly in specific long-dated strikes, often serves as a technical indicator of potential future price movements or a reflection of informed investor sentiment. It warrants closer scrutiny for shifts in the underlying stocks' dynamics.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment